These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 27047443)

  • 1. Embolic Strokes of Unknown Source and Cryptogenic Stroke: Implications in Clinical Practice.
    Nouh A; Hussain M; Mehta T; Yaghi S
    Front Neurol; 2016; 7():37. PubMed ID: 27047443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Approach to Working Up Cases of Embolic Stroke of Undetermined Source.
    Ryoo S; Chung JW; Lee MJ; Kim SJ; Lee JS; Kim GM; Chung CS; Lee KH; Hong JM; Bang OY
    J Am Heart Assoc; 2016 Mar; 5(3):e002975. PubMed ID: 27006118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cryptogenic stroke.
    Fonseca AC; Ferro JM
    Eur J Neurol; 2015 Apr; 22(4):618-23. PubMed ID: 25597418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic Stroke: Diagnostic Workup and Management.
    Mac Grory B; Flood SP; Apostolidou E; Yaghi S
    Curr Treat Options Cardiovasc Med; 2019 Dec; 21(11):77. PubMed ID: 31792625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related burden and characteristics of embolic stroke of undetermined source in the real world clinical practice.
    Grifoni E; Giglio D; Guazzini G; Cosentino E; Latini E; Dei A; Del Rosso A; Guarnaccia V; Baldini M; Bartolozzi ML; Martinucci P; Sani F; Giordano A; Dainelli F; Maggi F; Giulietti C; Romagnoli M; Cinotti S; Schipani E; Murgida GS; Di Martino S; Cozzi A; Carli Ballola A; Dacomo D; Valori D; Masotti L
    J Thromb Thrombolysis; 2020 Jan; 49(1):75-85. PubMed ID: 31494844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current perspectives on the clinical management of cryptogenic stroke.
    Yang D; Elkind MSV
    Expert Rev Neurother; 2023 Mar; 23(3):213-226. PubMed ID: 36934333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of atrial fibrillation among patients with an embolic stroke of undetermined source: Insights from insertable cardiac monitors.
    Verma N; Ziegler PD; Liu S; Passman RS
    Int J Stroke; 2019 Feb; 14(2):146-153. PubMed ID: 30196791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which Patent Foramen Ovales Need Closure to Prevent Cryptogenic Strokes?
    Dalen JE; Alpert JS
    Am J Med; 2018 Mar; 131(3):222-225. PubMed ID: 29175238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cryptogenic stroke management : where are we ?].
    Aubry P; Hamidouche F; Alqudwa A; Naoum-Nehme A; Maiga B; Camara N; Manchon E; Poulos N
    Ann Cardiol Angeiol (Paris); 2021 Dec; 70(6):373-379. PubMed ID: 34742466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.
    Umemura T; Nishizawa S; Nakano Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1810-1815. PubMed ID: 31097326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MRI in the Evaluation of Cryptogenic Stroke and Embolic Stroke of Undetermined Source.
    Xiao J; Poblete RA; Lerner A; Nguyen PL; Song JW; Sanossian N; Wilcox AG; Song SS; Lyden PD; Saver JL; Wasserman BA; Fan Z
    Radiology; 2024 Apr; 311(1):e231934. PubMed ID: 38652031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embolic strokes of undetermined source: the case for a new clinical construct.
    Hart RG; Diener HC; Coutts SB; Easton JD; Granger CB; O'Donnell MJ; Sacco RL; Connolly SJ;
    Lancet Neurol; 2014 Apr; 13(4):429-38. PubMed ID: 24646875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptogenic Strokes and Patent Foramen Ovales: What's the Right Treatment?
    Dalen JE; Alpert JS
    Am J Med; 2016 Nov; 129(11):1159-1162. PubMed ID: 27566504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryptogenic Stroke and Patent Foramen Ovale Risk Assessment.
    Melkumova E; Thaler DE
    Interv Cardiol Clin; 2017 Oct; 6(4):487-493. PubMed ID: 28886840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Embolic lesion pattern in stroke patients with patent foramen ovale compared with patients lacking an embolic source.
    Jauss M; Wessels T; Trittmacher S; Allendörfer J; Kaps M
    Stroke; 2006 Aug; 37(8):2159-61. PubMed ID: 16825590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new theory of cryptogenic stroke and its relationship to patent foramen ovale; or, the puzzle of the missing extra risk.
    Eggers AE
    Med Hypotheses; 2006; 67(5):1072-5. PubMed ID: 16814938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The P-wave terminal force in embolic strokes of undetermined source.
    Lattanzi S; Cagnetti C; Pulcini A; Morelli M; Maffei S; Provinciali L; Silvestrini M
    J Neurol Sci; 2017 Apr; 375():175-178. PubMed ID: 28320124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
    Tomita H; Sasaki S; Hagii J; Metoki N
    J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent foramen ovale as a risk factor for cryptogenic stroke.
    Di Tullio M; Sacco RL; Gopal A; Mohr JP; Homma S
    Ann Intern Med; 1992 Sep; 117(6):461-5. PubMed ID: 1503349
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.